References
- United Nations. Goal 3: ensure healthy lives and promote well-being for all at all ages; 2020.
- European Public Health Alliance. Universal Health Coverage, sustainable development and the pillar of social rights: implications and opportunities for the European Public Health Alliance; 2016.
- Universal Health Coverage 2030. Universal Health Coverage advocacy guide; 2018. https://www.uhc2030.org/fileadmin/uploads/uhc2030/Documents/Key_Issues/Advocacy/Advocacy_Guide_7_Jan_2019_gradient_r2.pdf .
- World Health Organization. Universal Health Coverage. https://www.who.int/news-room/fact-sheets/detail/universal-health-coverage-(uhc)
- World Health Organization. The world health report 2010 – health systems financing: the path to universal coverage. Geneva: World Health Organization; 2010. https://apps.who.int/iris/bitstream/handle/10665/44371/9789241564021_eng.pdf?sequence=1&isAllowed=y .
- World Health Organization. State of the world’s vaccines and immunization. World Health Organization; 2009. http://apps.who.int/iris/bitstream/handle/10665/44169/9789241563864_eng.pdf?sequence=1 .
- World Health Organisation. Polio endgame strategy 2019–2023; 2019. https://apps.who.int/iris/bitstream/handle/10665/329948/WHO-Polio-19.04-eng.pdf?sequence=1&isAllowed=y .
- Vanderslott S, Dadonaite B, and Roser M. Our world in data; 2019. https://ourworldindata.org/vaccination# .
- Abubakar I, Tillmann T, Banerjee A. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117–8.
- Reid M, Fleck F. The immunization programme that saved millions of lives. Bull World Health Organ. 2014;92:314–15.
- World Health Organization. Global immunization data; 2010. https://www.who.int/immunization/newsroom/global_immunization_data_english_may2010.pdf .
- World Health Organization. Immunization coverage; 2020. https://web.archive.org/web/20210220050552/https://www.who.int/news-room/fact-sheets/detail/immunization-coverage
- Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med. 2014;370:2211–18. doi:10.1056/NEJMra1213566.
- Kollmann TR, Kampmann B, Mazmanian SK, Marchant A, Levy O. Protecting the newborn and young infant from infectious diseases: lessons from immune ontogeny. Immunity. 2017;46:350–63. doi:10.1016/j.immuni.2017.03.009.
- Centers for Disease Control and Prevention. Pregnancy and vaccination; 2019. https://www.cdc.gov/vaccines/pregnancy/pregnant-women/need-to-know.html .
- Engmann C, Fleming JA, Khan S, Innis BL, Smith JM, Hombach J, Sobanjo-ter Meulen A. Closer and closer? Maternal immunization: current promise, future horizons. J Perinatol. 2020;40:844–57. doi:10.1038/s41372-020-0668-3.
- Keener A. Tailoring vaccines for older people and the very young. Nature. 2019;575:S48–S50. doi:10.1038/d41586-019-03638-6.
- Vojtek I, Dieussaert I, Doherty TM, Franck V, Hanssens L, Miller J, Bekkat-Berkani R, Kandeil W, Prado-Cohrs D, Vyse A, et al. Maternal immunization: where are we now and how to move forward? Ann Med. 2018;50:193–208. doi:10.1080/07853890.2017.1421320.
- Macrotrends. World life expectancy 1950-2021; 2021. https://www.macrotrends.net/countries/WLD/world/life-expectancy .
- United Nations. World population prospects; 2015. https://population.un.org/wpp/publications/files/key_findings_wpp_2015.pdf .
- United Nations. World population ageing; 2015. https://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2015_Report.pdf .
- Tyagi P. Double burden of communicable and non-communicable disease in old age in South Asia; 2014. https://www.helpage.org/silo/files/double-burden-of-disease-report.pdf .
- Quinton LJ, Walkey AJ, Mizgerd JP. Integrative physiology of pneumonia. Physiol Rev. 2018;98:1417–64. doi:10.1152/physrev.00032.2017.
- Gonfiantini M, Carloni E, Gesualdo F, Pandolfi E, Rizzuto E, Iannazzo S, Iannazzo S, Ciofi Degli Atti ML, Villani A, Tozzi AE, et al. Epidemiology of pertussis in Italy: disease trends over the last century. Eurosurveillance. 2014;19:20921. doi:10.2807/1560-7917.ES2014.19.40.20921.
- Office of Disease Prevention and Health Promotion. Immunization and infectious diseases; 2020. https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases .
- Garau J, Hodin MW, and Kalache A. Global coalition on aging; 2013. https://globalcoalitiononaging.com/wp-content/uploads/2018/07/life-course-immunization_gcoa-for-web-1.pdf .
- Hung IF, Leung AY, Chu DW, Leung D, Cheung T, Chan C-K, Lam C, Liu S-H, Chu C-M, Ho P-L, et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis. 2010;51:1007–16. doi:10.1086/656587.
- Curran D, Oostvogels L, Heineman T, Matthews S, McElhaney J, McNeil S, Diez-Domingo J, Lal H, Andrews C, Athan E, et al. Quality of life impact of an adjuvanted recombinant zoster vaccine in adults aged 50 years and older. J Gerontol A Biol Sci Med Sci. 2019;74:1231–38. doi:10.1093/gerona/gly150.
- Weinberger B, Grubeck‐Loebenstein B. Vaccines for the elderly. Clin Microbiol Infect. 2012;18:100–08. doi:10.1111/j.1469-0691.2012.03944.x.
- Mantel C, Cherian T. New immunization strategies: adapting to global challenges. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz. 2020;63:25–31. doi:10.1007/s00103-019-03066-x.
- Cesaro S, Giacchino M, Fioredda F, Barone A, Battisti L, Bezzio S, Frenos S, De Santis R, Livadiotti S, Marinello S, et al. Guidelines on vaccinations in paediatric haematology and oncology patients. BioMed Res Int. 2014;2014:707691. doi:10.1155/2014/707691.
- National Center for Immunization and Respiratory Diseases. General recommendations on immunization — recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations Rep 2011;60:1–64.
- Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand J Infect Dis. 2011;43:683–89. doi:10.3109/00365548.2011.582247.
- United Nations. Socio-economic impact of ebola virus disease in West African countries; 2015. https://www.undp.org/content/dam/rba/docs/Reports/ebola-west-africa.pdf .
- Kirigia JM, Muthuri RNDK, Muthuri NG. The monetary value of human lives lost through ebola virus disease in the Democratic Republic Of Congo in 2019. BMC Public Health. 2019;19:1218. doi:10.1186/s12889-019-7542-2.
- Suk JE, Paez Jimenez A, Kourouma M, Derrough T, Balde M, Honomou P, Kolie N, Mamadi O, Tamba K, Lamah K, et al. Post-Ebola measles outbreak in Lola, Guinea, January-June 2015(1). Emerg Infect Dis. 2016;22:1106–08. doi:10.3201/eid2206.151652.
- World Health Organization. Weekly epidemiological update - 16 February 2021; 2021.
- Cutler DM, and Summers LH. The COVID-19 pandemic and the $16 trillion virus. JAMA. 2020;324:1495–96. doi:10.1001/jama.2020.19759.
- Mandel A, Veetil V. The economic cost of COVID lockdowns: an out-of-equilibrium analysis. Econ Disaster Clim Chang. 2020;4:431–51. doi:10.1007/s41885-020-00066-z.
- Causey K, Fullman N, Sorensen RJ, Galles NC, Zheng P, Aravkin A, Danovaro-Holliday MC, Martinez-Piedra R, Sodha SV, and Velandia-González MP, et al. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study. Lancet. 2021;398:522–34. doi:10.1016/S0140-6736(21)01337-4.
- Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, Hamlet A, Smith JA, Winskill P, and Verity R, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8:e1132–e41. doi:10.1016/S2214-109X(20)30288-6.
- Ota MO, Badur S, Romano-Mazzotti L, Friedland LR. Impact of COVID-19 pandemic on routine immunization. Ann Med. 2021;53:2286–97. doi:10.1080/07853890.2021.2009128.
- Plotkin S, Robinson JM, Cunningham G, Iqbal R, Larsen S. The complexity and cost of vaccinemanufacturing–an overview. Vaccine. 2017;35:4064–71. doi:10.1016/j.vaccine.2017.06.003.
- Pronker E, Weenen T, Commandeur H, Osterhaus A, Claassen H. The gold industry standard for risk and cost of drug and vaccine development revisited. Vaccine. 2011;29:5846–49. doi:10.1016/j.vaccine.2011.06.051.
- Nabel G. Diseñando las vacunas del mañana. N Engl J Med. 2013;368:551–60. doi:10.1056/NEJMra1204186.
- Vandeputte J, Saville M, Cavaleri M, Friede M, Hacker A, Mueller SO, Rizzi R, Smith D, Thirstrup S, Wagner R, et al. IABS/CEPI platform technology webinar: is it possible to reduce the vaccine development time? Biologicals. 2021;71:55–60. doi:10.1016/j.biologicals.2021.04.005.
- Callaway E. The race for coronavirus vaccines: a graphical guide. Nature. 2020;580:576. doi:10.1038/d41586-020-01221-y.
- Greenwood B. The contribution of vaccination to global health: past, present and future. Philoso Trans R Soc Lond B Biol Sci. 2014;369:20130433. doi:10.1098/rstb.2013.0433.
- Doherty M, Buchy P, Standaert B, Giaquinto C, Prado- Cohrs D. Vaccine impact: benefits for human health. Vaccine. 2016;34:6707–14. doi:10.1016/j.vaccine.2016.10.025.
- Sim SY, Watts E, Constenla D, Brenzel L, Patenaude BN. Return on investment from immunization against 10 pathogens in 94 low- and middle-income countries, 2011-30. Health Affairs (Project Hope). 2020;39:1343–53. doi:10.1377/hlthaff.2020.00103.
- Stack ML, Ozawa S, Bishai DM, Mirelman A, Tam Y, Niessen L, Walker DG, Levine OS. Estimated economic benefits during the ‘decade of vaccines’ include treatment savings, gains in labor productivity. Health Aff. 2011;30:1021–28. doi:10.1377/hlthaff.2011.0382.
- Mihigo RM, Okeibunor JC, O’Malley H, Masresha B, Mkanda P, Zawaira F. Investing in life saving vaccines to guarantee life of future generations in Africa. Vaccine. 2016;34:5827–32. doi:10.1016/j.vaccine.2016.06.036.